Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Nature Medicine|May 26, 2022
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohortA Italiano, A Bessede, M Pulido, et al.
ESMO Open|September 18, 2022
Association between recent pregnancy or hormonal contraceptive exposure and outcome of desmoid-type fibromatosisM Debaudringhien, J-Y Blay, A-M Bimbai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2014
Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma GroupM Toulmonde, S Bonvalot, I Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2019
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)A Adenis, J Bennouna, P L Etienne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>P G Casali, A Le Cesne, A P Velasco, et al.
ESMO Open|May 9, 2022
Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 studyC Baldini, E Charton, E Schultz, et al.
ESMO Open|February 24, 2022
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)C Moreau-Bachelard, L Campion, M Toulmonde, et al.
ESMO Open|August 3, 2023
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 studyE Charton, C Baldini, Y Fayet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trialA Le Cesne, J-Y Blay, D Cupissol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapseJ-Y Blay, C Schiffler, O Bouché, et al.
Pageof 11